$15.01
0.27%
Nasdaq, Sep 12, 10:00 pm CET
ISIN
US0231112063
Symbol
AMRN

Amarin Corporation Plc Sponsored ADR Stock price

$15.01
+0.11 0.74% 1M
+7.01 87.58% 6M
+5.31 54.74% YTD
+3.37 29.00% 1Y
-12.79 46.01% 3Y
-70.39 82.42% 5Y
-33.19 68.86% 10Y
-286.99 95.03% 20Y
Nasdaq, Closing price Fri, Sep 12 2025
+0.04 0.27%
ISIN
US0231112063
Symbol
AMRN
Industry

Key metrics

Basic
Market capitalization
$310.9m
Enterprise Value
$12.2m
Net debt
positive
Cash
$298.7m
Shares outstanding
20.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.4 | 1.6
EV/Sales
0.1 | 0.1
EV/FCF
negative
P/B
0.7
Financial Health
Equity Ratio
70.9%
Return on Equity
-16.9%
ROCE
-10.6%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$219.4m | $196.8m
EBITDA
$-48.3m | $-52.9m
EBIT
$-51.2m | $-52.3m
Net Income
$-103.6m | $-51.7m
Free Cash Flow
$-11.5m
Growth (TTM | estimate)
Revenue
-17.2% | -13.9%
EBITDA
-102.6% | -1.1%
EBIT
-90.9% | 5.4%
Net Income
-209.1% | 37.1%
Free Cash Flow
-25.5%
Margin (TTM | estimate)
Gross
54.1%
EBITDA
-22.0% | -26.9%
EBIT
-23.3%
Net
-47.2% | -26.3%
Free Cash Flow
-5.3%
More
EPS
$-5.0
FCF per Share
$-0.6
Short interest
3.0%
Employees
275
Rev per Employee
$830.0k
Show more

Is Amarin Corporation Plc Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Amarin Corporation Plc Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Amarin Corporation Plc Sponsored ADR forecast:

3x Hold
38%
5x Sell
63%

Analyst Opinions

8 Analysts have issued a Amarin Corporation Plc Sponsored ADR forecast:

Hold
38%
Sell
63%

Financial data from Amarin Corporation Plc Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
219 219
17% 17%
100%
- Direct Costs 101 101
2% 2%
46%
119 119
27% 27%
54%
- Selling and Administrative Expenses 149 149
11% 11%
68%
- Research and Development Expense 21 21
2% 2%
9%
-48 -48
103% 103%
-22%
- Depreciation and Amortization 2.95 2.95
2% 2%
1%
EBIT (Operating Income) EBIT -51 -51
91% 91%
-23%
Net Profit -104 -104
209% 209%
-47%

In millions USD.

Don't miss a Thing! We will send you all news about Amarin Corporation Plc Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Amarin Corporation Plc Sponsored ADR Stock News

Neutral
GlobeNewsWire
15 days ago
-- Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanisms of Action -- -- Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanisms of Action --
Neutral
GlobeNewsWire
16 days ago
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High-Risk or Very High-Risk Patients Based on REDUCE-IT -- DUBLIN and BRIDGEWATER, N.J., Aug. 30, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted three sub-analyses from the REDUCE-IT® trial describing the impact of VASCEPA®/VAZKEPA® (icos...
Neutral
GlobeNewsWire
21 days ago
DUBLIN and BRIDGEWATER, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced upcoming presentations at the European Society of Cardiology (ESC) Congress 2025, August 29th-September 1st, in Madrid, Spain, where new data will further illuminate the multifaceted cardioprotective effects of icosapent ethyl (IPE).
More Amarin Corporation Plc Sponsored ADR News

Company Profile

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Head office United Kingdom
CEO Aaron Berg
Employees 275
Founded 1989
Website amarincorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today